Erschienen in:
01.05.2012 | Short Communication
Effect of biofeedback and deep oscillation on Raynaud’s phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial
verfasst von:
Birte Sporbeck, Kirsten Mathiske-Schmidt, Silke Jahr, Dörte Huscher, Mike Becker, Gabriela Riemekasten, Ines Taufmann, Gerd-Rüdiger Burmester, Stephanie Pögel, Anett Reisshauer
Erschienen in:
Rheumatology International
|
Ausgabe 5/2012
Einloggen, um Zugang zu erhalten
Abstract
Our aim was to evaluate the effect of deep oscillation and biofeedback on Raynaud’s phenomenon (RP) secondary to systemic sclerosis (SSc). A prospective randomized study was performed in SSc patients receiving either deep oscillation (n = 10) or biofeedback (n = 8) thrice a week for 4 weeks, or patients were randomized into the waiting group untreated for vasculopathy (n = 10) in time of running the study interventions. Biofeedback resulted in an improvement of RP as determined by score reduction of visual analogue scale compared with patients of the control group (P < 0.05), whereas deep oscillation revealed a tendency for improvement (P = 0.055). The study underlines the beneficial role of physiotherapy for the treatment of SSc-related RP.